164 related articles for article (PubMed ID: 6352079)
21. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
Silberbauer K; Punzengruber C; Sinzinger H
Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
[TBL] [Abstract][Full Text] [Related]
22. Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses.
Massie BM; Kramer BL; Topic N
Circulation; 1984 Jun; 69(6):1135-41. PubMed ID: 6370493
[TBL] [Abstract][Full Text] [Related]
23. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Sharpe DN; Coxon R
Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746
[TBL] [Abstract][Full Text] [Related]
24. Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.
Packer M; Medina N; Yushak M
Am J Cardiol; 1986 Jun; 57(15):1323-7. PubMed ID: 3521251
[TBL] [Abstract][Full Text] [Related]
25. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
Creager MA; Faxon DP; Weiner DA; Ryan TJ
Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
[TBL] [Abstract][Full Text] [Related]
26. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
27. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
[TBL] [Abstract][Full Text] [Related]
28. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
Packer M; Medina N; Yushak M
Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
[TBL] [Abstract][Full Text] [Related]
29. Combined vasodilator therapy for chronic congestive heart failure.
Cody RJ; Franklin KW; Laragh JH
Am Heart J; 1983 Apr; 105(4):575-80. PubMed ID: 6340448
[TBL] [Abstract][Full Text] [Related]
30. [Hemodynamic effects of the acute administration of captopril in refractory chronic congestive heart failure. Study of 13 patients and review of the literature].
Dall'Aglio V; Rellini G; Charmet P; Cassin M; Variola A; Menin A; Manfroni A; Meneguzzo N; Bazzi A
G Ital Cardiol; 1983 Sep; 13(9):153-9. PubMed ID: 6363191
[TBL] [Abstract][Full Text] [Related]
31. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
Levine TB; Cohn JN
Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
[TBL] [Abstract][Full Text] [Related]
32. Intravenous captopril in congestive heart failure.
Ahmad S; Giles TD; Roffidal LE; Haney Y; Given MB; Sander GE
J Clin Pharmacol; 1990 Jul; 30(7):609-14. PubMed ID: 2202753
[TBL] [Abstract][Full Text] [Related]
33. Hemodynamic effects of vasodilators and long-term response in heart failure.
Franciosa JA; Dunkman WB; Leddy CL
J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
Awan NA; Evenson MK; Needham KE; Win A; Mason DT
Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
[TBL] [Abstract][Full Text] [Related]
35. Acute hemodynamic action of captopril in congestive heart failure: contrasts between refractory and untreated patients.
Ferreira SR; Saragoça MA; Homsi E; Ajzen H; Draibe SA; Ribeiro AB; Ramos OL
J Clin Hypertens; 1987 Dec; 3(4):685-94. PubMed ID: 3330991
[TBL] [Abstract][Full Text] [Related]
36. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
Packer M; Medina N; Yushak M
Circulation; 1984 Dec; 70(6):1038-47. PubMed ID: 6388899
[TBL] [Abstract][Full Text] [Related]
37. Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure.
Awan NA; Amsterdam EA; Hermanovich J; Bommer WJ; Needham KE; Mason DT
Am Heart J; 1982 Apr; 103(4 Pt 1):474-9. PubMed ID: 6801943
[TBL] [Abstract][Full Text] [Related]
38. Captopril in refractory heart failure: clinical and hemodynamic observations.
Abinader EG; Sharif D; Rosenfeld T; Malouf S
Cardiology; 1983; 70(6):326-32. PubMed ID: 6370433
[TBL] [Abstract][Full Text] [Related]
39. Hemodynamic effects of captopril in essential hypertension, renovascular hypertension and cardiac failure: correlations with short- and long-term effects on plasma renin.
Wenting GJ; de Bruyn JH; Man in't Veld AJ; Woittiez AJ; Derkx FH; Schalekamp MA
Am J Cardiol; 1982 Apr; 49(6):1453-9. PubMed ID: 6803562
[No Abstract] [Full Text] [Related]
40. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
Sharpe DN; Coxon R
Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
